Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor–induced dermatologic adverse eventsSean Singer, Nicole R. LeBoeuf, Matthew S. Davids et al.|Journal of the American Academy of Dermatology|2019Cited by 44